Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus. The YESTONO Study

Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus. The YESTONO Study

Background: Effective blood pressure (BP) lowering therapy is regarded as the most important intervention in diabetes mellitus (DM). Nebivolol is commonly used for the treatment of hypertension (AH), but to date there has been no study of its use in a large population of hypertensive patients with t...

Full description

Bibliographic Details
Main Authors:	A. C. Schmidt, Ch. Graf, K. Brixius, J. Scholze
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2160

Similar Items

Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension
by: Huseyin Ugur Yazici, et al.
Published: (2013-01-01)

Nebivolol Increases Atrial Natriuretic Peptide/Systolic Blood Pressure Ratio in Hypertensive Patients
by: P.C. Papadopoulos, et al.
Published: (2008-01-01)

Effects of valsartan and nebivolol on blood pressure, QT dispersion and left ventricular hypertrophy in hypertensive patients
by: Luminita Lăţea, et al.
Published: (2010-06-01)

Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study
by: Renan Oliveira Vaz-de-Melo, et al.

Nebivolol for treatment patients with arterial hypertension
by: O M Mikheeva, et al.
Published: (2014-09-01)

Endothelium dysfunction at arterial hypertension: focus on nebivolol
by: Nikolay Aleksandrovich Vaulin
Published: (2009-03-01)

Arterial stiffness, hypertension, and rational use of nebivolol
by: Enrico Agabiti-Rosei, et al.
Published: (2009-05-01)

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
by: L.A. Fortepiani, et al.
Published: (2002-01-01)

Beta-adrenoblockers in arterial hypertension treatment: focus on nebivolol
by: D. Voytsekhovsky, et al.
Published: (2008-08-01)

Use of nebivolol in patients with mild and moderate hypertensive disease
by: L V Zhigunova, et al.
Published: (2003-03-01)

Prospective follow-up of nebivolol in the treatment of arterial hypertension
by: Despotović Nebojša, et al.
Published: (2012-01-01)

Efficacy and Safety of Nebivolol and Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Hyperlipidemia
by: Rhee MY, et al.
Published: (2020-11-01)

Beta-adrenoblocker nebivolol in the new Russian guidelines on arterial hypertension
by: L. G. Ratova, et al.
Published: (2008-08-01)

Nebivolol other beta blockers in patients with hypertension and erectile dysfunction
by: Randall P. Sharp, et al.
Published: (2017-02-01)

Effects of nebivolol on artery hypertension--multicentre study Bosnia and Herzegovina
by: Zumreta Kušljugić, et al.
Published: (2005-02-01)

A review of the safety and efficacy of nebivolol in the mildly hypertensive patient
by: John Cockcroft
Published: (2008-01-01)

Nebivolol effects on myocardial remodelling, inflammation markers and endothelial dysfunction in chronic heart failure patients with or without Type 2 diabetes mellitus
by: Yu. N. Belenkov, et al.
Published: (2011-02-01)

Peculiarities of Changes in Daily Blood Pressure and Its Variability in Patients with Essential Hypertension and Diabetes Mellitus Type 2
by: E.Yu. Gura
Published: (2014-09-01)

The role of vasodilating β-blockers in patients with complicated hypertension: focus on nebivolol
by: T. D. Giles
Published: (2011-12-01)

Nebivolol influence on cardiovascular system and kidneys in post-partum arterial hypertension
by: A. L. Vertkin, et al.
Published: (2005-04-01)

Use of nebivolol in patients with idiopathic pulmonary hypertension: Results of the pilot study
by: T V Martyniuk, et al.
Published: (2012-12-01)

Lichenoid type cutaneous hyperpigmentation induced by nebivolol
by: Abdullah Nabi Aslan, et al.
Published: (2017-04-01)

The Effect of Nebivolol on Office Blood Pressure of Blacks Residing in Sub-Saharan Africa (A Pilot Study)
by: Dike Ojji, et al.
Published: (2021-01-01)

Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke
by: Eleni Georgianou, et al.
Published: (2019-01-01)

Acute Effects of Cocoa Flavanols on Blood Pressure and Peripheral Vascular Reactivity in Type 2 Diabetes Mellitus and Essential Hypertension
by: Calders, P., et al.
Published: (2022)

Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus
by: Roland Asmar
Published: (2001-06-01)

Effect of telmisartan on arterial distensibility and central blood pressure in patients with mild to moderate hypertension and Type 2 diabetes mellitus
by: Roland Asmar
Published: (2001-06-01)

Beneficial Effects of Nebivolol in Comparison with Atenolol on Safety and Tolerability in Essential Hypertension
by: Vivek V. Bhosale, et al.
Published: (2014-06-01)

Nebivolol And Quinapril Reduce P-Wave Duration And Dispersion In Hypertensive Patients
by: Hasan Korkmaz, et al.
Published: (2009-05-01)

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015-09-01)

THE EFFECT OF NEBIVOLOL ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH MILD HYPERTENSION
by: I. L. Tepoyan, et al.
Published: (2015-09-01)

Brewer's Yeast Improves Blood Pressure in Type 2 Diabetes Mellitus
by: Payam Hosseinzadeh, et al.
Published: (2013-06-01)

Brewer's Yeast Improves Blood Pressure in Type 2 Diabetes Mellitus.
by: Payam Hosseinzadeh, et al.
Published: (2013-06-01)

Murottal Therapy Lowers Blood Pressure in Hypertensive Patients
by: Rastia Irmachatshalihah, et al.
Published: (2019-10-01)

HYPERTENSION AND DIABETES MELLITUS TYPE 2
by: M. E. Statsenko, et al.
Published: (2018-05-01)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
by: Yoann Rousselin, et al.
Published: (2012-12-01)

Different Types of Blood Pressure Variability in Hypertensive Patients with Chronic Lower Airway Diseases
by: M. I. Smirnova, et al.
Published: (2019-01-01)

Differences in circadian time structure of diastolic blood pressure between diabetes mellitus and essential hypertension
by: Matteucci Elena, et al.
Published: (2012-12-01)

Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan
by: Varagic J, et al.
Published: (2014-11-01)

Ambulatory Blood Pressure Monitoring and Circadian Rhythm of Blood Pressure in Diabetes Mellitus
by: Elena Matteucci, et al.
Published: (2013-10-01)